Dr. Levine is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
700 Childrens Dr
Columbus, OH 43205Phone+1 614-722-2000
Education & Training
- Nationwide Children's Hospital/Ohio State UniversityFellowship, Neonatal-Perinatal Medicine, 2022
- New York Presbyterian Hospital (Cornell Campus)Residency, Pediatrics, 2019 - 2022
- University of Louisville School of MedicineClass of 2019
Certifications & Licensure
- OH State Medical License 2022 - 2026
- American Board of Pediatrics Pediatrics
Publications & Presentations
PubMed
- 52 citationsCirculating myeloid-derived suppressor cells increase in patients undergoing neo-adjuvant chemotherapy for breast cancerRobert Wesolowski, Megan C. Duggan, Andrew Stiff, Joseph Markowitz, Prashant Trikha
Cancer Immunology, Immunotherapy. 2017-07-07 - 5 citationsA pilot study of interferon-alpha-2b dose reduction in the adjuvant therapy of high-risk melanoma.Lorena P. Suarez-Kelly, Kala M. Levine, Thomas Olencki, Sara E. Martin del Campo, Elizabeth A. Streacker
Cancer Immunology, Immunotherapy. 2019-02-06 - 80 citationsMiR-21 Enhances Melanoma Invasiveness via Inhibition of Tissue Inhibitor of Metalloproteinases 3 Expression: In Vivo Effects of MiR-21 InhibitorSara E. Martin del Campo, Nicholas Latchana, Kala M. Levine, Valerie P. Grignol, Ene T. Fairchild
Plos One. 2015-01-14
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: